Envestnet Asset Management Inc Replimune Group, Inc. Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 15,405 shares of REPL stock, worth $150,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,405Holding current value
$150,660% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding REPL
# of Institutions
166Shares Held
74MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$108 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$107 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$48 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$46.1 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.97MShares$38.8 Million8.12% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $482M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...